ТОП 20 - за 3 дня

заголовки анонсы
18:24 News-Medical.NetPioneering CRISPR therapy leaves two patients free of blood disease symptoms (1)

The first two clinical trials for CRISPR-based treatments for inherited blood disorders have been successful.

02:30 News-Medical.NetNew drug combo may improve pancreatic cancer therapy (1)

A new study by scientists at Sanford Burnham Prebys Medical Discovery Institute have discovered a combination of two cancer-fighting drugs that successfully worked on pancreatic tumor in mice, shrinking them significantly, and paving the way for a speedy clinical trial designed to test their efficacy in humans.

23:55 CancerNetwork.comNew Clinical Trial Aims to Reduce Malnutrition Among Patients with Lung Cancer (1)

Four cancer centers are joining forces on a new clinical trial designed to test medically tailored meals for patients with lung cancer to combat malnutrition.

23:39 News-Medical.NetCancer drug shows promise in treating metabolic syndrome (1)

Metabolic syndrome is a group of health problems characterized by the presence of elevated blood pressure, increased levels of triglycerides, high blood sugar, excess body fat around the waist, and obesity. If it’s left untreated, it can increase the risk of heart disease, stroke, and type 2 diabetes. Usually, treating metabolic syndrome involves targeting individual risk factors and modifying lifestyle practices.

21:06 News-Medical.Net'Dysbiosis' promotes the onset of colorectal cancer (1)

The gastroenterology team at Henri-Mondor AP-HP Hospital and University Paris-Est Créteil, led by Professor Iradj Sobhani, together with teams from Inserm and the Institut Pasteur Molecular Microbial Pathogenesis Unit (U1202), led by Professor Philippe Sansonetti - holder of the Microbiology and Infectious Diseases Chair at the Collège de France -, have demonstrated that an imbalance in the gut microbiota, also known as "dysbiosis", promotes the onset of colorectal cancer.